EFFECT OF INTERMITTENT DOSING REGIMENS OF ERLOTINIB ON METHYLNITROSOUREA-INDUCED MAMMARY CARCINOGENESIS

EGFR inhibitors are employed in therapy of lung and pancreatic cancers, and effectively prevent cancers in multiple animal models. Although daily dosing with erlotinib is effective, weekly dosing may reduce toxicity and have advantages, particularly for prevention. We tested alternative dosing regim...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lubet, Ronald A., Szabo, Eva, Iwata, Kenneth K., Gill, Stanley C., Tucker, Chris, Bode, Ann, Steele, Vernon E., Juliana, M. Margaret, Nicastro, Holly L., Grubbs, Clinton J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3813957/
https://ncbi.nlm.nih.gov/pubmed/23531447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-12-0322
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak